FDA — authorised 9 February 1959
- Marketing authorisation holder: AKORN
- Status: approved
🇺🇸 Spy Agent Green Kit in United States
FDA authorised Spy Agent Green Kit on 9 February 1959
Marketing authorisations
FDA — authorised 21 November 2018
- Application: NDA211580
- Marketing authorisation holder: NOVADAQ TECH
- Local brand name: SPY AGENT GREEN KIT
- Indication: POWDER — INTRAVENOUS, INTERSTITIAL
- Status: approved
Spy Agent Green Kit in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Spy Agent Green Kit approved in United States?
Yes. FDA authorised it on 9 February 1959; FDA authorised it on 21 November 2018.
Who is the marketing authorisation holder for Spy Agent Green Kit in United States?
AKORN holds the US marketing authorisation.